Zevra Therapeutics, Inc.ZVRANASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+111.7%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+111.7%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
9.5x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $149.62M | +4869.6% |
| 2024 | $-3.14M | -188.2% |
| 2023 | $3.56M | -77.4% |
| 2022 | $15.76M | +197.0% |
| 2021 | $-16.25M | -126.2% |
| 2020 | $-7.18M | -70.8% |
| 2019 | $-4.21M | -510.6% |
| 2018 | $-689000.00 | +93.2% |
| 2017 | $-10.06M | -148.0% |
| 2016 | $20.95M | - |